Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease

Neurobiology of Disease

Volumn 16, Issue 1, 2004, Pages 68-77

  Ryu, Jae K ^a,b,c   Kim, Jean ^a   Cho, Sung J ^a   Hatori, Kozo ^b   Nagai, Astushi ^b   Choi, Hyun B ^b,c   Lee, Min C ^d   McLarnon, James G ^c   Kim, Seung U ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Chonnam National University Medical School   (South Korea)

Author keywords

3 Nitropropionic acid; Brain transplantation; Brain derived neurotrophic factor; Human neural stem cells; Huntington disease; Striatum

Indexed keywords

CALBINDIN; CELL NUCLEUS ANTIGEN; GLUTAMATE DECARBOXYLASE; NEUROTROPHIC FACTOR; PROPIONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATION; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL; STEM CELL TRANSPLANTATION; STRIATE CORTEX; TASK PERFORMANCE;

ANIMALS; CELL LINE, TRANSFORMED; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MALE; NERVE DEGENERATION; NEURONS; RATS; RATS, INBRED LEW; STEM CELL TRANSPLANTATION; STEM CELLS; TELENCEPHALON;

EID: 2342562572     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.01.016     Document Type: Article

References (48)

1. Akerud P., Canals J.M., Snyder E.Y., Arenas E. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21:2001;8108-8118
2. Alston T.A., Mela L., Bright H.J. 3-Nitropropionate, the toxic substance of Indiofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. U. S. A. 74:1977;3767-3771
3. Armstrong R.J., Watts C., Svendsen C.N., Dunnett S.B., Rosser A.E. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant. 9:2000;55-64
4. Bachoud-Levi A.C., Remy P., Nguyen J.P., Brugieres P., Lefaucheur J.P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B., Boisse M.F., Grandmougin T., Jeny R., Bartolomeo P., Dalla Barba G., Degos J.D., Lisovoski F., Ergis A.M., Pailhous E., Cesaro P., Hantraye P., Peschanski M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet. 356:2000;1975-1979
5. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., Hyman B.T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:1993;4181-4192
6. Bemelmans A.P., Horellou P., Pradier L., Brunet I., Colin P., Mallet J. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum. Gene Ther. 10:1999;2987-2997
7. Bjorklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3:2000;537-544
8. Borlongan C.V., Koutouzis T.K., Sanberg P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci. Biobehav. Rev. 21:1997;289-293
9. Borlongan C.V., Koutouzis T.K., Poulos S.G., Saporta S., Sanberg P.R. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease. Cell Transplant. 7:1998;131-135
10. Brinkman R.R., Mezei M.M., Theilmann J., Almqvist E., Hayden M.R. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J. Hum. Genet. 60:1997;1202-1210
11. Brouillet E., Hantraye P., Ferrante R.J., Dolan R., Leroy-Willig A., Kowall N.W., Beal M.F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7105-7109
12. Bruce-Keller A.J., Umberger G., McFall R., Mattson M.P. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45:1999;8-15
13. Cho T., Bae J.H., Choi H.B., Kim S.S., McLarnon J.G., Suh-Kim H., Kim S.U., Min C.K. Human neural stem cells: electrophysiological properties of voltage-gated ion channels. Neuroreport. 13:2002;1447-1452
14. Coles C.J., Edmondson D.E., Singer T.P. Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biol. Chem. 254:1979;5161-5167
15. Dunnett S.B., Carter R.J., Watts C., Torres E.M., Mahal A., Mangiarini L., Bates G., Morton A.J. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp. Neurol. 154:1998;31-40
16. Flax J.D., Aurora S., Yang C., Simonin C., Wills A.M., Billinghurst L.L., Jendoubi M., Sidman R.L., Wolfe J.H., Kim S.U., Snyder E.Y. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16:1998;1033-1039
17. Freeman T.B., Cicchetti F., Hauser R.A., Deacon T.W., Li X.J., Hersch S.M., Nauert G.M., Sanberg P.R., Kordower J.H., Saporta S., Isacson O. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13877-13882
18. Fricker R.A., Carpenter M.K., Winkler C., Greco C., Gates M.A., Bjorklund A. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J. Neurosci. 19:1999;5990-6005
19. Gage F.H. Mammalian neural stem cells. Science. 287:2000;1433-1438
20. Greenamyre J.T., Shoulson I. Huntington's disease. Calne D.B. Neurodegenerative Disease. 1994;685-704 W.B. Saunders, Philadelphia
21. Harper P.S. Huntington's Disease. 1996;W.B. Saunders, London
22. Harris G.J., Codori A.M., Lewis R.F., Schmidt E., Bedi A., Brandt J. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain. 122:1999;1667-1678
23. Hsieh W.Y., Hsieh Y.L., Liu D.D., Yang S.N., Wu J.N. Neural progenitor cells resist excitatory amino acid-induced neurotoxicity. J. Neurosci. Res. 71:2003;272-278
24. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983
25. Hurelbrink C.B., Armstrong R.J.B., Dunnett S.B., Rosser A.E., Barker R.A. Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS. Eur. J. Neurosci. 15:2002;1255-1266
26. Kim S.U., Stern J., Kim M.W., Pleasure D.E. Culture of purified rat astrocytes in serum-free medium supplemented with mitogens. Brain Res. 274:1983;79-86
27. Kim S.U., Nakagawa E., Hatori K., Nagai A., Lee M.A., Bang J.H. Production of immortalized human neural crest cells. Zigova T., Sanberg P., Sanches-Ramos J. Neural Stem Cells: Methods and Protocols. 2002;55-65 Humana Press, Totowa, NJ
28. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P., et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1995;1118-1124
29. Kordower J.H., Freeman T.B., Chen E.Y., Mufson E.J., Sanberg P.R., Hauser R.A., Snow B., Olanow C.W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13:1998;383-393
30. Kust B.M., Copray J.C., Brouwer N., Troost D., Boddeke H.W. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp. Neurol. 177:2002;419-427
31. Leventhal L., Sortwell C.E., Hanbury R., Collier T.J., Kordower J.H., Palfi S. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. J. Comp. Neurol. 425:2000;471-478
32. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317
33. Liker M.A., Petzinger G.M., Nixon K., McNeill T., Jakowec M.W. Human neural stem cell transplantation in the MPTP-lesioned mouse. Brain Res. 971:2003;168-177
34. Martinez-Serrano A., Bjorklund A. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J. Neurosci. 16:1996;4604-4616
35. McKay R. Stem cells in the central nervous system. Science. 276:1997;66-71
36. Modo M., Rezaie P., Heuschling P., Patel S., Male D.K., Hodges H. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Brain Res. 958:2002;70-82
37. Nakao N., Itakura T. Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits. Prog. Neurobiol. 61:2000;313-338
38. Ourednik V., Ourednik J., Flax J.D., Zawada W.M., Hutt C., Yang C., Park K.I., Kim S.U., Sidman R.L., Freed C.R., Snyder E.Y. Segregation of human neural stem cells in the developing primate forebrain. Science. 293:2001;1820-1824
39. Ourednik J., Ourednik V., Lynch W.P., Schachner M., Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 20:2002;1103-1110
40. Palfi S., Conde F., Riche D., Brouillet E., Dautry C., Mittoux V., Chibois A., Peschanski M., Hantraye P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat. Med. 4:1998;963-966
41. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. 1998;Academic Press, San Diego
42. Pearlman S., Levivier M., Gash D.M. Striatal implants of fetal striatum or gelfoam protect against quinolinic acid lesions of the striatum. Brain Res. 613:1993;203-211
43. Perez-Navarro E., Canudas A.M., Akerund P., Alberch J., Arenas E. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J. Neurochem. 75:2000;2190-2199
44. Piccini P., Brooks D.J., Bjorklund A., Gunn R.N., Grasby P.M., Rimoldi O., Brundin P., Hagell P., Rehncrona S., Widner H., Lindvall O. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci. 2:1999;1137-1140
45. Ryu J.K., Choi H.B., Hatori K., Heisel R.L., Pelech S.L., McLarnon J.G., Kim S.U. Adenosine triphosphate induces proliferation of human neural stem cells: role of calcium and p70 ribosomal protein S6 kinase. J. Neurosci. Res. 72:2003;352-362
46. Seaton T.A., Cooper J.M., Schapira A.H. Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins. Brain Res. 809:1998;12-17
47. Thieben M.J., Duggins A.J., Good C.D., Gomes L., Mahant N., Richards F., McCusker E., Frackowiak R.S. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain. 125:2002;1815-1828
48. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using optical fractionator. Anat. Rec. 231:1991;482-497